Dawnrays Pharmaceutical (Holdings) logo

2348 - Dawnrays Pharmaceutical (Holdings) News Story

HK$1.07 0.0  0.0%

Last Trade - 2:12am

Sector
Healthcare
Size
Small Cap
Market Cap £158.3m
Enterprise Value £105.6m
Revenue £107.8m
Position in Universe 2246th / 5954

BRIEF-Dawnrays Pharmaceutical Enters Into MAH Assignment Agreement With Nanjing Haina

Tue 24th December, 2019 2:58pm
Dec 24 (Reuters) - Dawnrays Pharmaceutical (Holdings) Ltd
 2348.HK :
    * ENTERED INTO MAH ASSIGNMENT AGREEMENT WITH NANJING HAINA
    * NANJING HAINA IS TO ASSIGN MAH IN RESPECT OF FEBUXOSTAT
TABLETS
AND API TO SUZHOU DAWNRAYS
    * DEAL FOR RMB240 MILLION

Source text for Eikon:  urn:newsml:reuters.com:*:nHKSRRJk6
Further company coverage:  2348.HK 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.